Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TOMDF

Todos Med (CE) (TOMDF)

Todos Med Ltd (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:TOMDF
DateTimeSourceHeadlineSymbolCompany
07/17/20237:29AMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:TOMDFTodos Med Ltd (CE)
05/16/20232:07PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:TOMDFTodos Med Ltd (CE)
03/31/20233:04PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
03/31/20233:04PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:TOMDFTodos Med Ltd (CE)
03/29/20231:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TOMDFTodos Med Ltd (CE)
03/15/20239:02AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:TOMDFTodos Med Ltd (CE)
09/13/20223:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
09/13/20225:02AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:TOMDFTodos Med Ltd (CE)
09/01/20228:21AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
08/24/202211:41AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:TOMDFTodos Med Ltd (CE)
08/22/20223:05PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:TOMDFTodos Med Ltd (CE)
08/22/20223:04PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:TOMDFTodos Med Ltd (CE)
08/15/20223:33PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:TOMDFTodos Med Ltd (CE)
08/12/20223:05PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:TOMDFTodos Med Ltd (CE)
08/10/20223:41PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
08/05/20223:03PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
08/03/20228:48AMInvestorsHub NewsWireTodos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista DiagnosticsUSOTC:TOMDFTodos Med Ltd (CE)
05/16/20224:14PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:TOMDFTodos Med Ltd (CE)
04/06/20222:59PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TOMDFTodos Med Ltd (CE)
03/31/20225:17PMEdgar (US Regulatory)Annual Report (10-k)USOTC:TOMDFTodos Med Ltd (CE)
03/17/20225:05AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
02/07/20225:04AMEdgar (US Regulatory)Notice of Effectiveness (effect)USOTC:TOMDFTodos Med Ltd (CE)
01/27/20227:30AMInvestorsHub NewsWireTodos Medical and NLC Pharma Announce Primary and Secondary Endpoints Met in NLC-V-01 Phase 2 Clinical Trial of Oral Antiviral 3CL Protease Inhibitor Tollovir™ in the Treatment of Hospitalized COVID-19 PatientsUSOTC:TOMDFTodos Med Ltd (CE)
01/18/20223:04PMEdgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:TOMDFTodos Med Ltd (CE)
12/02/20219:39AMInvestorsHub NewsWireSA Breaking News - PURA expects to sign first contracts this monthUSOTC:TOMDFTodos Med Ltd (CE)
11/29/20213:02PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
11/16/20215:09AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
10/22/20212:06PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
09/27/20215:06AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:TOMDFTodos Med Ltd (CE)
09/24/20218:59AMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:TOMDFTodos Med Ltd (CE)
 Showing the most relevant articles for your search:USOTC:TOMDF